These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


370 related items for PubMed ID: 21973089

  • 1. Quantitative real-time PCR and the (1→3)-β-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization.
    Matsumura Y, Ito Y, Iinuma Y, Yasuma K, Yamamoto M, Matsushima A, Nagao M, Takakura S, Ichiyama S.
    Clin Microbiol Infect; 2012 Jun; 18(6):591-7. PubMed ID: 21973089
    [Abstract] [Full Text] [Related]

  • 2. Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization.
    Damiani C, Le Gal S, Da Costa C, Virmaux M, Nevez G, Totet A.
    J Clin Microbiol; 2013 Oct; 51(10):3380-8. PubMed ID: 23903553
    [Abstract] [Full Text] [Related]

  • 3. Serum (1 → 3) β-D-glucan assay for discrimination between Pneumocystis jirovecii pneumonia and colonization.
    Tasaka S, Kobayashi S, Yagi K, Asami T, Namkoong H, Yamasawa W, Ishii M, Hasegawa N, Betsuyaku T.
    J Infect Chemother; 2014 Nov; 20(11):678-81. PubMed ID: 25066434
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic accuracy of (1→3)-β-D-glucan to predict Pneumocystis jirovecii pneumonia in non-HIV-infected patients.
    Rogina P, Skvarc M.
    Radiol Oncol; 2020 May 28; 54(2):221-226. PubMed ID: 32463392
    [Abstract] [Full Text] [Related]

  • 5. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients.
    Alanio A, Desoubeaux G, Sarfati C, Hamane S, Bergeron A, Azoulay E, Molina JM, Derouin F, Menotti J.
    Clin Microbiol Infect; 2011 Oct 28; 17(10):1531-7. PubMed ID: 20946413
    [Abstract] [Full Text] [Related]

  • 6. Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients.
    Maillet M, Maubon D, Brion JP, François P, Molina L, Stahl JP, Epaulard O, Bosseray A, Pavese P.
    Eur J Clin Microbiol Infect Dis; 2014 Mar 28; 33(3):331-6. PubMed ID: 23990137
    [Abstract] [Full Text] [Related]

  • 7. Detection of Pneumocystis jirovecii by Quantitative PCR To Differentiate Colonization and Pneumonia in Immunocompromised HIV-Positive and HIV-Negative Patients.
    Fauchier T, Hasseine L, Gari-Toussaint M, Casanova V, Marty PM, Pomares C.
    J Clin Microbiol; 2016 Jun 28; 54(6):1487-1495. PubMed ID: 27008872
    [Abstract] [Full Text] [Related]

  • 8. Serum-based diagnosis of Pneumocystis pneumonia by detection of Pneumocystis jirovecii DNA and 1,3-β-D-glucan in HIV-infected patients: a retrospective case control study.
    Hammarström H, Grankvist A, Broman I, Kondori N, Wennerås C, Gisslen M, Friman V.
    BMC Infect Dis; 2019 Jul 23; 19(1):658. PubMed ID: 31337356
    [Abstract] [Full Text] [Related]

  • 9. Pneumocystis polymerase chain reaction and blood (1→3)-β-D-glucan assays to predict survival with suspected Pneumocystis jirovecii pneumonia.
    Matsumura Y, Ito Y, Yamamoto M, Matsushima A, Nagao M, Takakura S, Iinuma Y, Ichiyama S.
    J Infect Chemother; 2014 Feb 23; 20(2):109-14. PubMed ID: 24480550
    [Abstract] [Full Text] [Related]

  • 10. Impact of HIV Infection Status on Interpretation of Quantitative PCR for Detection of Pneumocystis jirovecii.
    Louis M, Guitard J, Jodar M, Ancelle T, Magne D, Lascols O, Hennequin C.
    J Clin Microbiol; 2015 Dec 23; 53(12):3870-5. PubMed ID: 26468505
    [Abstract] [Full Text] [Related]

  • 11. Ability of quantitative PCR to discriminate Pneumocystis jirovecii pneumonia from colonization.
    Perret T, Kritikos A, Hauser PM, Guiver M, Coste AT, Jaton K, Lamoth F.
    J Med Microbiol; 2020 May 23; 69(5):705-711. PubMed ID: 32369002
    [Abstract] [Full Text] [Related]

  • 12. Comparison of 2 real-time PCR assays for diagnosis of Pneumocystis jirovecii pneumonia in human immunodeficiency virus (HIV) and non-HIV immunocompromised patients.
    Montesinos I, Brancart F, Schepers K, Jacobs F, Denis O, Delforge ML.
    Diagn Microbiol Infect Dis; 2015 Jun 23; 82(2):143-7. PubMed ID: 25801778
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of a real-time PCR for diagnosis of Pneumocystis pneumonia in immunocompromised patients - Experience from a tertiary care center, India.
    S D, S TD, Gupta R, Varughese S, Varghese GM, George B, Michael JS.
    J Mycol Med; 2022 May 23; 32(2):101241. PubMed ID: 34999296
    [Abstract] [Full Text] [Related]

  • 14. Recent Advances in the Diagnosis of Pneumocystis Pneumonia.
    Song Y, Ren Y, Wang X, Li R.
    Med Mycol J; 2016 May 23; 57(4):E111-E116. PubMed ID: 27904052
    [Abstract] [Full Text] [Related]

  • 15. Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients.
    Huggett JF, Taylor MS, Kocjan G, Evans HE, Morris-Jones S, Gant V, Novak T, Costello AM, Zumla A, Miller RF.
    Thorax; 2008 Feb 23; 63(2):154-9. PubMed ID: 17693588
    [Abstract] [Full Text] [Related]

  • 16. Serum (1,3)-Beta-d-Glucan has suboptimal performance for the diagnosis of Pneumocystis jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR.
    Szvalb AD, Malek AE, Jiang Y, Bhatti MM, Wurster S, Kontoyiannis DP.
    J Infect; 2020 Sep 23; 81(3):443-451. PubMed ID: 32650108
    [Abstract] [Full Text] [Related]

  • 17. Clinical Performance of (1,3) Beta-D Glucan for the Diagnosis of Pneumocystis Pneumonia (PCP) in Cancer Patients Tested With PCP Polymerase Chain Reaction.
    Morjaria S, Frame J, Franco-Garcia A, Geyer A, Kamboj M, Babady NE.
    Clin Infect Dis; 2019 Sep 27; 69(8):1303-1309. PubMed ID: 30561560
    [Abstract] [Full Text] [Related]

  • 18. [Investigation of Pneumocystis jirovecii Infection and Colonization in Immunocompromised Patients with Pneumonia].
    Gülbudak H, Öztürk C, Kuyugöz S, Tezcan Ülger S.
    Mikrobiyol Bul; 2020 Oct 27; 54(4):583-595. PubMed ID: 33107287
    [Abstract] [Full Text] [Related]

  • 19. Beta-d-Glucan for Diagnosing Pneumocystis Pneumonia: a Direct Comparison between the Wako β-Glucan Assay and the Fungitell Assay.
    Mercier T, Guldentops E, Patteet S, Beuselinck K, Lagrou K, Maertens J.
    J Clin Microbiol; 2019 Jun 27; 57(6):. PubMed ID: 30918045
    [Abstract] [Full Text] [Related]

  • 20. Real-time PCR is more specific than conventional PCR for induced sputum diagnosis of Pneumocystis pneumonia in immunocompromised patients without HIV infection.
    Fujisawa T, Suda T, Matsuda H, Inui N, Nakamura Y, Sato J, Toyoshima M, Nakano Y, Yasuda K, Gemma H, Hayakawa H, Chida K.
    Respirology; 2009 Mar 27; 14(2):203-9. PubMed ID: 19210645
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.